Skip to main content
. 2017 Feb 24;4(1):15. doi: 10.3390/bioengineering4010015

Table 2.

Scaffolds provided with a mesoporous coating.

Coating Base scaffold Processing Effect References
58S Al2O3 Dip-coating Improved bioactivity in vitro [32]
58S Al2O3/ZrO2 Dip-coating Improved bioactivity in vitro [33]
58S/PCL Calcium phosphate Dipping Improved mechanical properties [34]
58S Bovine hydroxyapatite Dipping Improved mechanical properties [35]
SBA-15 Glass–ceramic Dipping Drug release [36]
MCM-41 Glass–ceramic Dipping Drug release [37,38,39]
MBG Glass–ceramic Electrophoretic deposition Improved bioactivity in vitro [45,46]
MBG β-TCP Spin coating Improved bioactivity in vitro [47]
MBG/PLGA CaSiO3 Dipping Improved bioactivity in vitro and mechanical properties, drug release [48]
Cu-doped MBG Hydroxyapatite Dipping Drug release and antibacterial effect due to the release of Cu2+ ions [49]
MBG Phosphate glass fibers Thermal bonding Improved bioactivity in vitro, drug release [50]
MBG PLLA Dip-coating Improved bioactivity in vitro, drug release [53]
PCL/gelatin/sol-gel glass Magnesium Freeze-drying Improved bioactivity in vitro, reduction of magnesium dissolution [56]